#Serotonin_Uptake_Inhibitors

  1. Efficacy of selective serotonin reuptake inhibitors in the absence of side effects: A mega-analysis of citalopram and paroxetine in adult depression
  2. Cross-sectional networks of depressive symptoms before and after antidepressant medication treatment
  3. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations
  4. Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: Results from the CO-MED trial
  5. Selective serotonin reuptake inhibitors for unipolar depression: A systematic review of classic long-term randomized controlled trials
  6. How often do SSRIs and other new-generation antidepressants lose their effect during continuation treatment? Evidence suggesting the rate of true tachyphylaxis during continuation treatment is low
  7. Publication bias in systematic reviews
  8. Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant Action
  9. Escitalopram maintenance treatment for prevention of recurrent depression: A randomized, placebo-controlled trial
  10. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: A meta-analysis
  11. Two items on the Hamilton Depression rating scale are effective predictors of remission: Comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine
  12. Fixed-dose trial of the single isomer SSRI Escitalopram in depressed outpatients
  13. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo
  14. Efficacy of SSRIs and newer antidepressants in severe depression: Comparison with TCAs
  15. The treatment of severe depression: Is there an efficacy gap between SSRI and TCA antidepressant generations?
  16. Placebo-controlled efficacy of antidepressants in continuation treatment